Mycophenolate Mofetil and Risk of Developing Malignancy After Orthotopic Heart Transplantation: Analysis of the Transplant Registry of the International Society for Heart and Lung Transplantation

The choice of immunosuppressive regimen may affect the likelihood of developing malignancy after OHT. Induction immunosuppression does not appear to increase the risk of subsequent malignancy. The use of MMF in standard immunosuppressive regimens is associated with a significantly lower risk of developing malignancy.